GSK-2827408

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGSK-2827408
Drug Alias Namesecond generation RET kinase inhibitors (GlaxoSmithKline/WuXi Apptec/University of Oklahoma)GSK-408GSK-2827408
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase receptor RET inhibitors
TargetsTyrosine-protein kinase receptor RET
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Oklahoma Health Sciences CenterGlaxosmithkline PlcWuxi Apptec Co Ltd
Active IndicationsN/A
Inactive IndicationsIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A